Pharmaceuticals

Growth In The Non-Viral Gene Delivery Technologies Market Is Being Driven By Rising Adoption Of Targeted Therapies Driving Growth Of The Due To Advancements In Personalized Medicine

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Does The Market Size Of The Non-Viral Gene Delivery Technologies Market Compare Between 2026 And 2030?

The non-viral gene delivery technologies market size has seen rapid expansion in recent years. It is anticipated to increase from $4.57 billion in 2025 to $5.28 billion in 2026, with a compound annual growth rate (CAGR) of 15.5%. This historical growth can be attributed to several factors, including a reliance on viral delivery methods, the limited availability of non-viral transfection reagents, a rising interest in gene therapy research, the increasing adoption of plasmid dna and mrna delivery kits, and the use of electroporation and various physical delivery techniques.

The non-viral gene delivery technologies market is expected to experience substantial expansion in the coming years, with its size projected to reach $9.26 billion in 2030, growing at a compound annual growth rate (CAGR) of 15.1%. This anticipated growth is attributed to factors such as the development of advanced lipid and polymer nanoparticles, the expansion of pre-formulated nanoparticle technologies, increasing investment in gene editing and RNAi therapeutics, a rising demand for personalized gene therapy solutions, and the integration of high-throughput and automated delivery platforms. Major trends foreseen for this period include a greater adoption of lipid-based and polymer-based non-viral delivery systems, an increase in CRISPR and Cas9 gene editing applications, growing demand for RNAi and DNA vaccine delivery platforms, the expansion of ex-vivo and in-vivo gene therapy research, and the development of cell-specific and targeted gene delivery reagents.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27367&type=smp

What Key Factors Are Affecting The Non-Viral Gene Delivery Technologies Market Demand?

The escalating need for personalized medicine is projected to stimulate expansion within the non-viral gene delivery technologies market in the coming period. This medical methodology, personalized medicine, tailors prevention, diagnosis, and treatment by considering an individual’s distinct genetic composition, way of life, and environmental factors. The rising need for personalized medicine stems from breakthroughs in genomic sequencing technologies, enabling more precise diagnoses, focused treatments, and better patient-specific therapeutic results. This heightened emphasis on personalized medicine fuels the demand for non-viral gene delivery technologies because these provide safer and more flexible ways to introduce therapeutic genes suited to a person’s genetic profile, circumventing the dangers linked with viral vectors. An illustration of this trend is seen in February 2024, when the Personalized Medicine Coalition, a US-based non-profit body, reported that the Food and Drug Administration (FDA) sanctioned 16 new personalized treatments for rare disease patients in 2023, which is an increase from 6 approvals in 2022. Consequently, the expanding requirement for personalized medicine is propelling the development of the non-viral gene delivery technologies market.

How Is The Non-Viral Gene Delivery Technologies Market Organized By Segment Classification?

The non-viral gene delivery technologies market covered in this report is segmented –

1) By Product: Reagents And Kits, Delivery Devices, Pre-Formulated Nanoparticles

2) By Delivery: In-Vitro, In-Vivo, Ex-Vivo

3) By Technology: Electroporation, Lipid-Based Transfection, Polymer-Based Transfection, Physical Methods (Microinjection, Gene Gun), Nanoparticles

4) By Application: Gene Therapy, Deoxyribonucleic Acid (DNA) Vaccines, Ribonucleic Acid Interference (RNAi), Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Or Cas9 Gene Editing, Protein Expression

5) By End-Use: Biotechnology And Biopharmaceutical Companies, Research And Academic Institutes, Other End-Uses

Subsegments:

1) By Reagents And Kits: Transfection Reagents, Plasmid Deoxyribonucleic Acid (DNA) Kits, Messenger Ribonucleic Acid (RNA) Delivery Kits, Small Interfering Ribonucleic Acid (RNA) Delivery Kits, Clustered Regularly Interspaced Short Palindromic Repeats Associated Protein Reagents, Cell-Specific Delivery Reagents

2) By Delivery Devices: Electroporation Systems, Microinjection Systems, Gene Guns Or Biolistic Delivery Devices, Ultrasound-Mediated Delivery Devices, Hydrodynamic Gene Delivery Systems

3) By Pre-Formulated Nanoparticles: Lipid-Based Nanoparticles, Polymer-Based Nanoparticles, Gold-Based Nanoparticles, Dendrimer-Based Nanoparticles, Carbon Nanotube-Based Nanoparticles, Inorganic Compound-Based Nanoparticles

What Trends Are Influencing The Non-Viral Gene Delivery Technologies Market?

Leading companies within the non-viral gene delivery market are concentrating on developing advanced solutions, such as non-viral genetic medicine platforms, to enhance the safety and effectiveness of gene therapies. A non-viral genetic medicine platform is a technology designed to introduce therapeutic genes or nucleic acids into cells without the use of viruses, thereby minimizing immune reactions and safety concerns, and enabling precise and controlled gene therapy delivery for a multitude of diseases. For instance, in October 2023, Generation Bio Co., a US-based biotechnology company focused on genetic medicine development, unveiled immune-quiet DNA (iqDNA). This novel DNA represents an optimized variant of their closed-ended DNA (ceDNA) that successfully evades innate immune detection, exhibiting cytokine levels and tolerability comparable to chemically modified mRNA in studies involving mice and non-human primates when administered via their lipid nanoparticle (LNP) system. Owing to iqDNA’s superior tolerability, Generation Bio is progressing with this as the primary DNA cargo in all its initiatives, including its foremost hemophilia A program.

Who Are The Industry Participants Involved In The Non-Viral Gene Delivery Technologies Market?

Major companies operating in the non-viral gene delivery technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Evonik Industries AG, Moderna Inc., Lonza Group AG, Bio-Rad Laboratories Inc., Takara Bio Inc., GenScript Biotech Corporation, ReCode Therapeutics Inc., Altogen Biosystems Inc., Generation Bio, Indee Labs Inc.

Get The Full Non-Viral Gene Delivery Technologies Market Report:

https://www.thebusinessresearchcompany.com/report/non-viral-gene-delivery-technologies-global-market-report

Which Region Accounts For The Largest Portion Of The Non-Viral Gene Delivery Technologies Market?

North America was the largest region in the non-viral gene delivery technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the non-viral gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Non-Viral Gene Delivery Technologies Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/non-viral-gene-delivery-technologies-global-market-report

Browse Through More Reports Similar to the Global Non-Viral Gene Delivery Technologies Market 2026, By The Business Research Company

Low Density Polyethylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/low-density-polyethylene-global-market-report

Polyethylene Pipes Market Report 2026

https://www.thebusinessresearchcompany.com/report/polyethylene-pipes-global-market-report

High Density Polyethylene Market Report 2026

https://www.thebusinessresearchcompany.com/report/high-density-polyethylene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795